Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al

Basit Öğe Kaydı
dc.authorscopusid14322526100
dc.authorscopusid57205694005
dc.authorscopusid8247039800
dc.contributor.authorYalta K.
dc.contributor.authorOzkan U.
dc.contributor.authorYalta T.
dc.date.accessioned2024-06-12T10:25:33Z
dc.date.available2024-06-12T10:25:33Z
dc.date.issued2021
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1136/heartjnl-2021-320124
dc.identifier.issn1355-6037
dc.identifier.issue23en_US
dc.identifier.pmid34656974en_US
dc.identifier.scopus2-s2.0-85121957640en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1922en_US
dc.identifier.urihttps://doi.org/10.1136/heartjnl-2021-320124
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16378
dc.identifier.volume107en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofHearten_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCotransporter; Glucose; Sodium; Adverse Event; Heart Failure; Human; Glucose; Heart Failure; Humans; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Symportersen_US
dc.titleCorrespondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et alen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu